Cited by 8

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

L-type Amino Acid Transporter 1 (SLC7A5)-Mediated Transport of Pregabalin at the Rat Blood-Spinal Cord Barrier and its Sensitivity to Plasma Branched-Chain Amino Acids

Akashi, Tomoya, Noguchi, Saki, Takahashi, Yu, Nishimura, Tomohiro, Tomi, Masatoshi·2023·Journal of Pharmaceutical Sciences

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xphs.2022.12.028

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 31

  1. Colloca, 2017, Neuropathic pain, Nat Rev Dis Primers, 3, 1, 10.1038/nrdp.2017.2 · DOI
  2. Murphy, 2020, Peripheral neuropathic pain, NeuroRehabilitation, 47, 265
  3. Field, 2006, Identification of the α2-δ-1 subunit of voltage-calcium calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin, Proc Natl Acad Sci U S A, 103, 17537, 10.1073/pnas.0409066103 · DOI
  4. Chincholkar, 2018, Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review, Br J Anaesth, 120, 1315, 10.1016/j.bja.2018.02.066 · DOI
  5. Vongveeranonchai, 2014, Evaluation of a patient with spinal cord infarction after a hypotensive episode, Stroke, 45, e203, 10.1161/STROKEAHA.114.006490 · DOI
  6. Uchida, 2020, Comparison of absolute protein abundances of transporters and receptors among blood-brain barriers at different cerebral regions and the blood-spinal cord barrier in humans and rats, Mol Pharm, 17, 2006, 10.1021/acs.molpharmaceut.0c00178 · DOI
  7. Uchida, 2019, Involvement of claudin-11 in disruption of blood-brain, -spinal cord, and -arachnoid barriers in multiple sclerosis, Mol Neurobiol, 56, 2039, 10.1007/s12035-018-1207-5 · DOI
  8. Benet, 2011, BDDCS Applied to over 900 drugs, AAPS J, 13, 519, 10.1208/s12248-011-9290-9 · DOI
  9. Su, 2005, Mediation of highly concentrative uptake of pregabalin by L-type amino acid transport in Chinese hamster ovary and Caco-2 cells, J Pharmacol Exp Ther, 313, 1406, 10.1124/jpet.104.082255 · DOI
  10. Takahashi, 2018, Transport of pregabalin via L-type amino acid transporter 1 (SLC7A5) in human brain capillary endothelial cell line, Pharm Res, 35, 10.1007/s11095-018-2532-0 · DOI
  11. Toyooka, 2008, Up-regulation of L type amino acid transporter 1 after spinal cord injury in rats, Acta Neurochir Suppl (Wien), 385, 10.1007/978-3-211-85578-2_74 · DOI
  12. Lamhonwah, 2008, Expression patterns of the organic cation/carnitine transporter family in adult murine brain, Brain Dev, 30, 31, 10.1016/j.braindev.2007.05.005 · DOI
  13. Watson, 2013, Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier, BMC Neurosci, 14, 1, 10.1186/1471-2202-14-59 · DOI
  14. Noguchi, 2021, Substrate recognition of renally eliminated angiotensin II receptor blockers by organic anion transporter 4, Drug Metab Pharmacokinet, 36, 10.1016/j.dmpk.2020.10.002 · DOI
  15. Dhanikula, 2016, Evaluation of P-glycoprotein expression in pain relevant tissues: understanding translation of efflux from preclinical species to human, ADMET DMPK, 4, 261, 10.5599/admet.4.3.305 · DOI
  16. Oda, 2010, l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth, Cancer Sci, 101, 173, 10.1111/j.1349-7006.2009.01386.x · DOI
  17. Yanagida, 2001, Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines, Biochim Biophys Acta Biomembr, 1514, 291, 10.1016/S0005-2736(01)00384-4 · DOI · Paper page
  18. del Amo, 2008, Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2, Eur J Pharm Sci, 35, 161, 10.1016/j.ejps.2008.06.015 · DOI
  19. Berry, 2005, Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC, Ther Drug Monit, 27, 451, 10.1097/01.ftd.0000158874.54100.1a · DOI
  20. Takahashi, 2018, Transport of pregabalin via L-type amino acid transporter 1 (SLC7A5) in human brain capillary endothelial cell line, Pharm Res, 35, 246, 10.1007/s11095-018-2532-0 · DOI
  21. Blasberg, 1983, Transport of α-aminoisobutyric acid across brain capillary and cellular membranes, J Cereb Blood Flow Metab, 3, 8, 10.1038/jcbfm.1983.2 · DOI
  22. Otsuki, 2017, Prostate cancer cells in different androgen receptor status employ different leucine transporters, Prostate, 77, 222, 10.1002/pros.23263 · DOI
  23. Blum, 2021, Single-cell transcriptomic analysis of the adult mouse spinal cord reveals molecular diversity of autonomic and skeletal motor neurons, Nat Neurosci, 24, 572, 10.1038/s41593-020-00795-0 · DOI · Paper page
  24. Fukushima, 2007, Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis, Hepatol Res, 37, 765, 10.1111/j.1872-034X.2007.00123.x · DOI
  25. Zhang, 2011, Effects of branched-chain amino acid supplementation on plasma concentrations of free amino acids, insulin, and energy substrates in young men, J Nutr Sci Vitaminol (Tokyo), 57, 114, 10.3177/jnsv.57.114 · DOI
  26. Adibi, 1973, Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals, Journal of Clinical Investigation, 52, 1586, 10.1172/JCI107335 · DOI
  27. Kadota, 2012, Clofibrate-induced reduction of plasma branched-chain amino acid concentrations impairs glucose tolerance in rats, J Parenter Enter Nutr, 36, 337, 10.1177/0148607111414578 · DOI
  28. Knapik-Czajka, 2009, Adverse effect of fenofibrate on branched-chain α-ketoacid dehydrogenase complex in rat's liver, Toxicology, 266, 1, 10.1016/j.tox.2009.10.002 · DOI
  29. Cucca, 2015, Amino acid supplementation in l-dopa treated Parkinson's disease patients, Clin Nutr, 34, 1189, 10.1016/j.clnu.2014.12.007 · DOI
  30. Leenders, 1986, Inhibition ofL-{18F}fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography, Ann Neurol, 20, 258, 10.1002/ana.410200212 · DOI
  31. Dickens, 2013, Transport of gabapentin by LAT1 (SLC7A5), Biochem Pharmacol, 85, 1672, 10.1016/j.bcp.2013.03.022 · DOI

Cited by

Sorted by citations

Metadata

Authors
Akashi, T., Noguchi, S., Takahashi, Y., Nishimura, T., & Tomi, M.
Venue
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Published
2023-04
Volume
112
Issue
4
Pages
1137-1144
ISSN
0022-3549
Cited by
8
References
3
Language
en
Funders
Japan Society for the Promotion of Science (18H03183, 21H02651, 22K20723)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review